Relative Bioavailability Study of Lipidil Supra (Fenofibrate 160mg) Versus SYO-0805 (Fenofibrate 65mg) in Normal Healthy Subjects.

Trial Profile

Relative Bioavailability Study of Lipidil Supra (Fenofibrate 160mg) Versus SYO-0805 (Fenofibrate 65mg) in Normal Healthy Subjects.

Completed
Phase of Trial: Phase I

Latest Information Update: 17 Dec 2012

At a glance

  • Drugs Fenofibrate (Primary)
  • Indications Hypercholesterolaemia; Hypertriglyceridaemia
  • Focus Pharmacokinetics
  • Most Recent Events

    • 19 Oct 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 03 Aug 2011 Planned end date Aug 2011 added as reported by ClinicalTrials.gov.
    • 03 Aug 2011 Actual initiation date Jun 2011 added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top